Literature DB >> 3878688

Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

A W Pasculle, J N Dowling, F N Frola, D A McDevitt, M A Levi.   

Abstract

Several antimicrobial agents were evaluated for activity against experimental Legionella micdadei pneumonia in guinea pigs. Erythromycin, rifampin, doxycycline, and sulfamethoxazole-trimethoprim produced significant reductions in mortality. Penicillin, cefazolin, cefoxitin, chloramphenicol, and gentamicin were not efficacious even though, at the doses administered, the peak concentrations of these agents in serum substantially exceeded their MICs for the test strain. It is suggested that the poor performance of the latter group of agents resulted from poor penetration into cells in which L. micdadei was multiplying.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878688      PMCID: PMC180318          DOI: 10.1128/AAC.28.6.730

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium.

Authors:  B H Rogers; G R Donowitz; G K Walker; S A Harding; M A Sande
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

2.  Lethal gram-negative bacterial superinfection in Guinea pigs given bacitracin.

Authors:  W E Farrar; T H Kent; V B Elliott
Journal:  J Bacteriol       Date:  1966-08       Impact factor: 3.490

3.  Antimicrobial susceptibility of intracellular Legionella pneumophila.

Authors:  M A Bacheson; H M Friedman; C E Benson
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

4.  Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens.

Authors:  P H Edelstein
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

5.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

6.  Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function.

Authors:  R A Seger; S Baumgartner; L X Tiefenauer; F K Gmünder
Journal:  Helv Paediatr Acta       Date:  1981

7.  Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography.

Authors:  T B Vree; Y A Hekster; A M Baars; J E Damsma; E V Kleijin
Journal:  J Chromatogr       Date:  1978-07-01

8.  Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.

Authors:  P H Edelstein; K Calarco; V K Yasui
Journal:  Am Rev Respir Dis       Date:  1984-11

9.  New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.

Authors:  J Toro; K Sawatari; T Kanda; A Saito; K Hara
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

10.  Pittsburgh pneumonia agent: direct isolation from human lung tissue.

Authors:  A W Pasculle; J C Feeley; R J Gibson; L G Cordes; R L Myerowitz; C M Patton; G W Gorman; C L Carmack; J W Ezzell; J N Dowling
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

View more
  7 in total

Review 1.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

Review 2.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.

Authors:  P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Increased recovery of Legionella micdadei and Legionella bozemanii on buffered charcoal yeast extract agar supplemented with albumin.

Authors:  W E Morrill; J M Barbaree; B S Fields; G N Sanden; W T Martin
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.

Authors:  J L Vildé; E Dournon; P Rajagopalan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Laboratory and clinical evaluation of a commercial DNA probe for the detection of Legionella spp.

Authors:  A W Pasculle; G E Veto; S Krystofiak; K McKelvey; K Vrsalovic
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.